Literature DB >> 10952253

Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?

R J Fontana, A S Lok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10952253     DOI： 10.1016/s0168-8278(00)80376-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late?

Authors:  Henry Lik-Yuen Chan
Journal:  Dig Dis Sci       Date:  2010-08       Impact factor: 3.199

2.  The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study.

Authors:  Cengiz Bolukbas; Fusun Filiz Bolukbas; Tulin Kendir; Nihat Akbayir; Ali Tuzun Ince; Evren Abut; Mehmet Horoz; Ali Remzi Dalay; Mehmet Haci Sokmen; Oya Ovunc
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 3.  Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.

Authors:  Francisco Rodriguez-Frias; Maria Buti; David Tabernero; Maria Homs
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.